Showing results (1-10 of 236) with videos related to
Sort By:
Pageof 24
Rheumatic Diseases Clinics of North America|July 3, 2021
Innovative Trials and New Opportunities in SLEYashaar Chaichian, Daniel J WallaceThe Journal of Clinical Investigation|February 19, 2019
A promising approach to targeting type 1 IFN in systemic lupus erythematosusYashaar Chaichian, Daniel J Wallace, Michael H WeismanClinical Rheumatology|January 7, 2021
Interferon-directed therapies for the treatment of systemic lupus erythematosus: a critical updateYashaar Chaichian, Vibeke StrandRheumatic Diseases Clinics of North America|April 8, 2014
Long-term management of gout: nonpharmacologic and pharmacologic therapiesYashaar Chaichian, Saima Chohan, Michael A BeckerRheumatic Diseases Clinics of North America|September 28, 2020
Increasing Ancestral Diversity in Lupus Trials: Ways ForwardTitilola Falasinnu, Yashaar Chaichian, Julia F SimardJournal of Women'S Health (2002)|September 12, 2017
Impact of Sex on Systemic Lupus Erythematosus-Related Causes of Premature Mortality in the United StatesTitilola Falasinnu, Yashaar Chaichian, Julia F SimardClinical Rheumatology|February 20, 2021
Pulse dose steroid experience among hospitalized patients with systemic lupus erythematosus: a single-center feasibility studyYashaar Chaichian, Michael H Weisman, Julia F SimardClinical Rheumatology|March 15, 2020
The road to rheumatoid arthritis prevention: challenges and opportunitiesYashaar Chaichian, Mark C Genovese, Michael H WeismanPublic Health Reports (Washington, D.C. : 1974)|June 22, 2018
Do Death Certificates Underestimate the Burden of Rare Diseases? The Example of Systemic Lupus Erythematosus Mortality, Sweden, 2001-2013Titilola Falasinnu, Marios Rossides, Yashaar Chaichian, et al.ACR Open Rheumatology|November 29, 2019
Unraveling Race, Socioeconomic Factors, and Geographical Context in the Heterogeneity of Lupus Mortality in the United StatesTitilola Falasinnu, Yashaar Chaichian, Latha Palaniappan, et al.Pageof 24